Nasus Pharma Ltd — Form D

Nasus Pharma Ltd of TEL AVIV, L3, a company, filed a Form D exempt-offering notice with the SEC on 2026-02-25. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Biotechnology.

Offering

Filed: 2026-02-25
Form: D
Accession: 0001493152-26-008057
Industry: Biotechnology
Exemptions: 06b
Total offering: $15.0M
Amount sold: $15.0M
Investors: 15
Date of first sale: 2026-02-10
Security types: equity
Revenue range: No Revenues
SEC file number: 021-574660

Issuer

Name: Nasus Pharma Ltd
CIK: 0002029039
Entity type: Corporation
Jurisdiction: ISRAEL
Address: 34 YITZHAK SADEH ST, TEL AVIV, L3, 6274711
Phone: +972.3.573.6632

Officers, directors & promoters (10)

Name	Role	Location
Udi Gilboa	Director	TEL AVIV, L3
Ronnie Hershman	Director	TEL AVIV, L3
Isaac Israel	Director	TEL AVIV, L3
Dalia Megiddo	Director	TEL AVIV, L3
Sharon Shacham	Director	TEL AVIV, L3
David Silberman	Director	New York, NY
DAN TELEMAN	Director	NESS ZIONA, L3
Dalia Megiddo	Executive Officer	TEL AVIV, L3
Eyal Rubin	Executive Officer	TEL AVIV, L3
DAN TELEMAN	Executive Officer	NESS ZIONA, L3

More